Plasma biomarkers for early detection of alzheimer’s disease: a cross-sectional study in a Japanese cohort

Abstract Background Plasma biomarkers offer a promising alternative to amyloid beta (Aβ) positron emission tomography (PET) or cerebrospinal fluid (CSF) biomarkers for diagnosing Alzheimer’s disease (AD). This cross-sectional study assessed the utility of multiple plasma biomarkers for diagnosing an...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Masahito Kubota, Shogyoku Bun, Keisuke Takahata, Shin Kurose, Yuki Momota, Yu Iwabuchi, Toshiki Tezuka, Hajime Tabuchi, Morinobu Seki, Yasuharu Yamamoto, Ryo Shikimoto, Yu Mimura, Takayuki Hoshino, Sho Shimohama, Natsumi Suzuki, Ayaka Morimoto, Azusa Oosumi, Yuka Hoshino, Kenji Tai, Hirofumi Aoyagi, Yoshiaki Sato, Junro Kuromitsu, Jin Nakahara, Masaru Mimura, Daisuke Ito
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2025-06-01
Serija:	Alzheimer’s Research & Therapy
Teme:	Alzheimer’s disease Plasma biomarkers Aβ42/40 p-tau217 p-tau217/Aβ42 HISCL
Online dostop:	https://doi.org/10.1186/s13195-025-01778-8
Oznake:	Označite Brez oznak, prvi označite!